1. Home
  2. ZD vs NVAX Comparison

ZD vs NVAX Comparison

Compare ZD & NVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ziff Davis Inc.

ZD

Ziff Davis Inc.

N/A

Current Price

$54.66

Market Cap

1.9B

ML Signal

N/A

Logo Novavax Inc.

NVAX

Novavax Inc.

N/A

Current Price

$10.64

Market Cap

1.7B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ZD
NVAX
Founded
1995
1987
Country
United States
United States
Employees
N/A
749
Industry
Advertising
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.9B
1.7B
IPO Year
1999
1996

Fundamental Metrics

Financial Performance
Metric
ZD
NVAX
Price
$54.66
$10.64
Analyst Decision
Buy
Buy
Analyst Count
6
9
Target Price
★ $63.67
$14.00
AVG Volume (30 Days)
531.8K
★ 4.4M
Earning Date
11-05-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 309.76
EPS
★ 17.49
N/A
Revenue
★ $1,364,028,000.00
$1,123,479,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$1.46
N/A
P/E Ratio
$3.22
★ N/A
Revenue Growth
N/A
★ 64.69
52 Week Low
$22.45
$6.20
52 Week High
$60.48
$11.85

Technical Indicators

Market Signals
Indicator
ZD
NVAX
Relative Strength Index (RSI) 47.72 66.82
Support Level $54.64 $8.42
Resistance Level $57.48 $10.85
Average True Range (ATR) 1.63 0.51
MACD -0.29 0.03
Stochastic Oscillator 12.31 85.83

Price Performance

Historical Comparison
ZD
NVAX

About ZD Ziff Davis Inc.

Ziff Davis Inc is a digital media and internet company operating a portfolio of brands across technology, shopping, gaming and entertainment, health and wellness, connectivity, and cybersecurity. The company has five reportable segments. The Technology & Shopping segment generates revenue from advertising and commerce content. The Gaming & Entertainment segment provides content, subscriptions, and digital storefront services. The Health & Wellness segment offers digital tools and content for health management. The Connectivity segment provides data and analytics solutions for network performance. The Cybersecurity & Martech segment delivers cloud-based software for security and marketing. It generates the majority of its revenue from the Health & Wellness segment.

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, an in-house early-stage R&D business to build a pipeline of high-value assets using its technology along with seeking to enter into partnerships to drive value creation for its assets.

Share on Social Networks: